Overview

Multi-omics integration addresses the challenge of combining diverse molecular data types — genome, transcriptome, proteome, and metabolome — to construct a coherent, systems-level picture of a biological system. No single omics layer captures the full complexity of cellular regulation; genomic mutations may not alter transcript levels, transcript abundance often does not correlate with protein abundance due to post-translational regulation, and metabolite levels reflect the integrated output of all upstream layers. Integration strategies aim to bridge these gaps and reveal how perturbations propagate across molecular scales.

Methods

Integration approaches fall into three categories. Concatenation-based methods merge all omics features into a single matrix for joint analysis by clustering or classification. Transformation-based methods convert each omics dataset into an intermediate representation — such as a kernel matrix or a network — before combining them. Model-based methods use probabilistic graphical models or deep learning architectures such as variational autoencoders to learn shared latent representations across data types. Tools like MOFA (Multi-Omics Factor Analysis) and mixOmics identify common and data-type-specific variation patterns. Data preprocessing is critical: batch effects, missing values, and differing dynamic ranges must be addressed before integration.

Applications

Multi-omics integration drives precision medicine by stratifying patients into molecular subtypes based on combined genomic, transcriptomic, and proteomic profiles. In cancer research, integrated analysis links copy-number alterations from DNA microarrays and gene expression data to protein-level changes measured by proteomics and mass spectrometry, and maps these onto disrupted metabolic pathways. Integrative approaches also reveal regulatory mechanisms by correlating epigenetic marks with transcript and protein abundance, providing a truly holistic view of cellular function.